Panama vs Puerto Rico: Paying taxes: Time to complete a corporate income tax correction
Paying taxes: Time to complete a corporate income tax correction over time
- Panama
- Puerto Rico
How they compare
Puerto Rico currently reports 104.86 DB17-20 methodology against 99.29 DB17-20 methodology in Panama, a difference of 5.57 DB17-20 methodology.
That makes Puerto Rico's figure about 1.1 times Panama's.
Across all 5 years both countries report, Puerto Rico has been ahead every year.
Panama ranks 3rd and Puerto Rico ranks 2nd of 181 countries.
Puerto Rico has averaged higher in every one of the 1 decades both report.
Frequently asked questions
- Which has higher paying taxes: time to complete a corporate income tax correction, Panama or Puerto Rico?
- Puerto Rico, at 104.86 DB17-20 methodology against 99.29 DB17-20 methodology in Panama as of 2019.
- What is the difference in paying taxes: time to complete a corporate income tax correction between Panama and Puerto Rico?
- 5.57 DB17-20 methodology, with Puerto Rico ahead.
- How many years of comparable data are there for Panama and Puerto Rico?
- 5 years are reported by both, from 2015 to 2019.
- How do Panama and Puerto Rico rank globally for paying taxes: time to complete a corporate income tax correction?
- Panama ranks 3rd and Puerto Rico ranks 2nd of 181 countries.
- Where does this data come from?
- The World Bank, published as Paying taxes: Time to complete a corporate income tax correction (weeks) (DB17-20 methodology). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Time to complete a corporate income tax correction (weeks) (DB17-20 methodology) measures the time to complete a review by the tax authority including a formal tax audit if in 25% or more of cases, a company that voluntarily reports an error in its corporate income tax return and an underpayment of the tax due would be selected for additional review. The component indicator is computed based on the methodology in the DB17-20 studies.